Organocatalyst streamlines oligonucleotide drug synthesis

A new organocatalytic reaction offers a simpler way to make an important class of drugs based on modified nucleic acid chains. The catalyst eliminates the need for temporary molecular guides that are currently needed to control phosphorus stereochemistry during the synthesis of phosphorothioate oligonucleotides used in several approved RNA therapies.